Video

Jan Geissler Explains Differing Perceptions for Living With CML

Perceptions of chronic myelogenous leukemia (CML) and how to live with it are very different for patients and physicians, and a strong dialogue is needed to overcome the disparity, according to Jan Geissler, co-founder of the CML Advocates Network.

Perceptions of chronic myelogenous leukemia (CML) and how to live with it are very different for patients and physicians, and a strong dialogue is needed to overcome the disparity, according to Jan Geissler, co-founder of the CML Advocates Network.

At the 56th Annual Meeting of the American Society of Hematology in San Francisco, California, December 6-9, he discussed how there has been a lot of movement and a number of studies in the past years to help understand how CML patients perceive quality of life and severity of side effects.

“Especially in CML we’ve seen a lot of movement, because a very lethal disease, in the last 15 years, has turned into a chronic disease,” Mr Geissler said.

Related Videos
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Andrew Kuykendall, MD, Moffitt Cancer Center
Screenshot of an interview with Shaun McKenzie, MD
Sabarish Ayyappan, MD
Sabarish Ayyappan, MD
Frederick L. Locke, MD
Screenshot of an interview with Shaun McKenzie, MD
Screenshot of an interview with Rohan Garje, MD
Susan Escudier, MD, FACP
Sabarish Ayyappan, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo